Pharmaceutical industry – Page 20
-
BusinessBuilding a biological biocide
Aqualution Systems produces stable hypochlorous acid, a natural biocide up to 300 times more effective than bleach
-
NewsWhy jury verdicts get overruled in US industry cancer trials
Judges often end up intervening post-trial in complex cases with conflicting scientific evidence
-
NewsWindow of opportunity to deal with harmful chemicals closing, UN warns
Innovative solutions needed as report acknowledges governments and businesses won’t hit 2020 targets
-
-
ResearchCo-crystals fish out cannabinoid from plant extract
Purifying cannabidiol from natural cannabis extract made cheap and easy thanks to amino acid partner
-
BusinessNurturing the next biotech generation
As incubator environments evolve, options for new companies looking for support are broadening
-
ArticleSmall particles making a big splash in clinical development
Nanoform is investigating how to tackle clinical attrition rates through nanonisation of APIs
-
ArticleInvestigating multi-dimensional problems in drug substance development
Finding solutions to the biggest challenges faced during drug substance development relies on properly integrating analytical and production expertise
-
NewsEU sets goal of tackling pharmaceutical pollution in the environment
Commission identifies six areas to take action on
-
BusinessSmartwound dressings spot infection early
Bacterial toxins burst dye-filled vesicles to give a visual warning
-
NewsUniversity sues professor for taking graduate’s research that he stands to make millions from
University of Missouri–Kansas City pharmacy researcher accused of stealing inventions related to a novel eye drug delivery formulation, sold it for $1.5m plus royalties
-
OpinionWe’re going to need a bigger flask
Scaling up reactions is easy to get wrong in a variety of ways
-
OpinionDivergent reality
If the UK leaves the EU without a deal, the two will inevitably drift further apart
-
BusinessWhat might Brexit mean for industry?
Questions hang over regulation, trade, talent and investment
-
-
OpinionIn search of ultimate selectivity
A catalyst that reacts only with aryl iodides, spurning bromides and chlorides
-
NewsBig costs, no benefits to UK’s replacement for EU chemical regulation
Industry warns small volume chemicals could no longer be sold in the UK
-
BusinessUK government sets out antimicrobial resistance plan
Aims to cut antibiotic use and explore financial incentives for pharmaceutical companies
-
BusinessBattling the US opioid epidemic
Adapt pharma’s naloxone nasal spray makes treating overdoses easier
-
ResearchPatent-busting AI tool navigates around protected drug pathways
Organic retrosynthesis software can identify key bonds involved in patented reactions to find alternative pathways